Long-term studies of patients on continuous GLP-1 therapy show sustained weight loss maintenance, improved cardiovascular outcomes, and normalized appetite signaling over years of treatment
Diabetologia 58 , 28102818 (2015)
This is a chronic process, and we may have to have chronic treatmentand its not their fault, and its not lack of effort, its not lack of doing the best they can
It is important to emphasise that Ozempic is not currently licensed for insulin resistance in the absence of type 2 diabetes, nor for prediabetes, despite promising trial data
The same 5 mg dose can be a different number of units in two different vials
I have been steadily losing weight and Im happy with the results so far